FAKTOR OPTIONSSCHEIN - AMGEN | Real-time Boerse Frankfurt Warrants 18:34:51 13/05/2024 BST | ||
| 3.94 EUR | +6.49% |
|
| Current month | -52.13% | ||
| 1 month | -58.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/24 | 3.94 | +6.49% | 0 |
| 10/05/24 | 3.7 | +0.54% | 0 |
| 09/05/24 | 3.68 | -11.33% | 0 |
| 08/05/24 | 4.15 | -5.68% | 0 |
| 07/05/24 | 4.4 | +0.23% | 0 |
Real-time Boerse Frankfurt Warrants
Last update May 13, 2024 at 06:34 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UM2P5C |
| ISIN | DE000UM2P5C3 |
| Date issued | 01/02/2024 |
| Strike | 391.1 $ |
| Maturity | Unlimited |
| Parity | 19.38 : 1 |
| Emission price | 5.14 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.51 € |
|---|---|
| Lowest since issue | 2.94 € |
| Spread | 0.15 € |
| Spread % | 3.69% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat
